RAPID RESULTS
Results in 20 minutes.
Can improve patient outcomes
By providing faster results, medical professionals can offer earlier therapeutic interventions without needing additional resources or third party labs. This can help redirect critical patients.
PATIENT FRIENDLY
Less invasive testing.
A quick process with minimal discomfort
No uncomfortable nasal swabs or blood draw required. A few drops of blood can determine whether a patient has been exposed to the virus within the past 4 to 24 days or longer.
INFECTION STAGING
Determine the infection time from 4-24 days.
Diagnostic Assay
By measuring the concentration of these particular antibodies, the SARS-CoV-2 Rapid Test can determine in 20 minutes whether you have been exposed to the virus within the past 4 to 24 days or even longer.
POINT-OF-CARE
Designed for healthcare professionals.
Designed for healthcare professionals
The COVID-19 Rapid Test is intended for the use by trained healthcare professionals. The COVID-19 Rapid Test is only for use under the Food and Drug Administration's Emergency Use Authorization.
Dedicated to putting patients first.
More Info
If you are located in the United States and would like more information about our CoV-2 Rapid Test, please note that this product is only available to laboratories, hospitals and clinical professionals. The test will be available and distributed by Vivera Pharmaceuticals, Inc. to health care providers throughout the United States. We are unable to respond to inquiries from the general public.
All NPI numbers will be validated prior to order acceptance.
For urgent inquiries please call (844) 484-8372.
Interview with Tucker Carlson Tonight
News & Media
CBS discussing CoV-2 Rapid Test
